Advisory Research Inc. reduced its position in shares of Analogic Co. (NASDAQ:ALOG) by 9.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 687,152 shares of the medical research company’s stock after selling 70,929 shares during the period. Analogic comprises approximately 1.0% of Advisory Research Inc.’s portfolio, making the stock its 29th largest position. Advisory Research Inc. owned approximately 5.51% of Analogic worth $57,549,000 at the end of the most recent quarter.
Several other institutional investors have also recently added to or reduced their stakes in the company. Koch Industries Inc. raised its stake in Analogic by 8,505.7% during the 2nd quarter. Koch Industries Inc. now owns 321,335 shares of the medical research company’s stock worth $317,000 after acquiring an additional 317,601 shares in the last quarter. Northern Trust Corp raised its stake in Analogic by 53.5% during the 2nd quarter. Northern Trust Corp now owns 372,687 shares of the medical research company’s stock worth $27,075,000 after acquiring an additional 129,855 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in Analogic by 4.1% during the 3rd quarter. Dimensional Fund Advisors LP now owns 947,627 shares of the medical research company’s stock worth $79,364,000 after acquiring an additional 37,066 shares in the last quarter. Acadian Asset Management LLC acquired a new stake in Analogic during the 4th quarter worth $3,102,000. Finally, Vanguard Group Inc. raised its stake in Analogic by 3.1% during the 2nd quarter. Vanguard Group Inc. now owns 1,147,408 shares of the medical research company’s stock worth $83,359,000 after acquiring an additional 34,765 shares in the last quarter. 93.90% of the stock is owned by institutional investors and hedge funds.
Analogic Co. (NASDAQ:ALOG) opened at $84.85 on Wednesday. The company has a market cap of $1,059.95, a price-to-earnings ratio of -14.83, a price-to-earnings-growth ratio of 4.24 and a beta of 0.82. Analogic Co. has a one year low of $66.00 and a one year high of $89.50.
Several equities research analysts recently commented on the stock. Zacks Investment Research upgraded shares of Analogic from a “hold” rating to a “buy” rating and set a $97.00 price target on the stock in a research note on Friday, December 8th. Jefferies Group reiterated a “hold” rating and set a $80.00 price target on shares of Analogic in a research note on Friday, December 8th. Finally, BidaskClub lowered shares of Analogic from a “sell” rating to a “strong sell” rating in a research note on Saturday, January 6th.
TRADEMARK VIOLATION WARNING: This piece was reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are accessing this piece on another domain, it was stolen and reposted in violation of US and international copyright and trademark law. The original version of this piece can be accessed at https://stocknewstimes.com/2018/02/21/analogic-co-alog-shares-sold-by-advisory-research-inc.html.
Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.
Receive News & Ratings for Analogic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic and related companies with MarketBeat.com's FREE daily email newsletter.